BioPharma Credit Plc
(OTC) BOPCF
BioPharma Credit Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$258.83M
Net Income (TTM)
$232.48M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.07
Beta (Volatility)
0.08 (Low)
Dividend
$0.07
Beta (Volatility)
0.08 (Low)
Price
$0.88
Volume
157
Open
$0.88
Price
$0.88
Volume
157
Open
$0.88
Previous Close
$0.88
Daily Range
$0.88 - $0.88
52-Week Range
$0.76 - $0.93
Dividend
$0.07
Beta (Volatility)
0.08 (Low)
Price
$0.88
Volume
157
Open
$0.88
Previous Close
$0.88
Daily Range
$0.88 - $0.88
52-Week Range
$0.76 - $0.93
BOPCF News
BOPCF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioPharma Credit Plc
BOPCF Financials
Key Financial Metrics (TTM)
Gross Margin
1%
Operating Margin
1%
Net Income Margin
1%
Return on Equity
0%
Return on Capital
11%
Return on Assets
11%
Earnings Yield
N/A
Dividend Yield
0.08%
Payout Ratio
97.93%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
157
Short Interest
0.00%
Avg. Volume
12.14K
Financials (TTM)
Gross Profit
$124.46M
Operating Income
$122.18M
EBITDA
$122.18M
Operating Cash Flow
$111.91M
Capital Expenditure
$0.00
Free Cash Flow
$111.91M
Cash & ST Invst.
$5.62M
Total Debt
$0.00
BioPharma Credit Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$77.15M
-1.7%
Gross Profit
$83.78M
+6.7%
Gross Margin
1.09%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
0
N/A
Net Income
$72.78M
+2.6%
EBITDA
$0.00
-100.0%
Quarterly Fundamentals
Net Cash
$4.30M
-93.7%
Accounts Receivable
$54.21M
+37.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
10.63%
N/A
Return on Invested Capital
10.68%
N/A
Free Cash Flow
$33.76M
+11.0%
Operating Cash Flow
$33.76M
+11.0%